Alan Peter Hill
GlaxoSmithKline
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alan Peter Hill.
Journal of Medicinal Chemistry | 2013
Panayiotis A. Procopiou; John Barrett; Nicholas Paul Barton; Malcolm Begg; David E. Clapham; Royston C. B. Copley; Alison J. Ford; Rebecca H. Graves; David A. Hall; Ashley Paul Hancock; Alan Peter Hill; Heather Hobbs; Simon Teanby Hodgson; Coline Jumeaux; Yannick Maurice Louis Lacroix; Afjal H. Miah; Karen Morriss; Deborah Needham; Emma B. Sheriff; Robert J. Slack; Claire E. Smith; Steven L. Sollis; Hugo Staton
A series of indazole arylsulfonamides were synthesized and examined as human CCR4 antagonists. Methoxy- or hydroxyl-containing groups were the more potent indazole C4 substituents. Only small groups were tolerated at C5, C6, or C7, with the C6 analogues being preferred. The most potent N3-substituent was 5-chlorothiophene-2-sulfonamide. N1 meta-substituted benzyl groups possessing an α-amino-3-[(methylamino)acyl]-group were the most potent N1-substituents. Strongly basic amino groups had low oral absorption in vivo. Less basic analogues, such as morpholines, had good oral absorption; however, they also had high clearance. The most potent compound with high absorption in two species was analogue 6 (GSK2239633A), which was selected for further development. Aryl sulfonamide antagonists bind to CCR4 at an intracellular allosteric site denoted site II. X-ray diffraction studies on two indazole sulfonamide fragments suggested the presence of an important intramolecular interaction in the active conformation.
Drug Discovery Today | 2011
Robert J. Young; Darren V. S. Green; Christopher N. Luscombe; Alan Peter Hill
Archive | 1991
Alan Duncan Robertson; Alan Peter Hill; Robert Charles Glen; Graeme Richard Martin
Drug Discovery Today | 2010
Alan Peter Hill; Robert J. Young
Journal of Medicinal Chemistry | 1995
Robert C. Glen; Graeme Richard Martin; Alan Peter Hill; Hyde Rm; Woollard Pm; Salmon Ja; Buckingham J; Alan Duncan Robertson
Journal of Medicinal Chemistry | 2005
Simon J. F. Macdonald; Rachel Cameron; Derek Anthony Demaine; Rob J. Fenton; Graham Foster; David Gower; J. Nicole Hamblin; Stephanie Hamilton; Graham J. Hart; Alan Peter Hill; Graham G. A. Inglis; Betty Jin; Haydn Terence Jones; Darryl Mcconnell; Jennifer L. McKimm-Breschkin; Gail Mills; Van T. T. Nguyen; Ian J. Owens; Nigel R. Parry; Stephen E. Shanahan; Donna L. Smith; Keith Geoffrey Watson; ‡ and Wen-Yang Wu; Simon P. Tucker
Journal of Medicinal Chemistry | 2001
Karamjit S. Jandu; Vikki Barrett; Michael Brockwell; David Cambridge; Duncan R. Farrant; Christopher James Foster; Heather Giles; Robert C. Glen; Alan Peter Hill; Heather Hobbs; Andrew Honey; Graeme Richard Martin; John Salmon; Donna Smith; and Patrick Woollard; David L. Selwood
Journal of Pharmaceutical Sciences | 2011
Klara Valko; Shenaz Nunhuck; Alan Peter Hill
Journal of Medicinal Chemistry | 2017
Stephen Brand; Eun Jung Ko; Elisabet Viayna; Stephen Thompson; Daniel Spinks; Michael George Thomas; Lars Sandberg; Amanda Fortes Francisco; Shiromani Jayawardhana; Victoria Smith; Chimed Jansen; Manu De Rycker; John Thomas; Lorna MacLean; Maria Osuna-Cabello; Jennifer Riley; Paul Scullion; Laste Stojanovski; Frederick R. C. Simeons; Ola Epemolu; Yoko Shishikura; Sabrinia Crouch; Tania Bakshi; Christopher J. Nixon; Iain H. Reid; Alan Peter Hill; Tim Underwood; Sean J. Hindley; Sharon Robinson; John M. Kelly
Archive | 2011
Ara L. Valk; Shenaz Nunhuck; Alan Peter Hill